Clinical Trial Update: Effect of Low-dose Interferon-alfa2a on Peri-operative Immune Suppression [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating low-dose interferon-alfa2a for peri-operative immune suppression in colon cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• Interferon-alfa2a (low-dose) (interferon alfa-2a)

Snippet

Sponsor: Zealand University Hospital | Conditions: Colon Cancer | Phase 2 | Status: UNKNOWN